Management of Elevated TSH and Low Free T4

Initial Assessment and Diagnosis

Elevated TSH with low free T4 is diagnostic of primary hypothyroidism, requiring thyroid hormone replacement therapy, as recommended by the American College of Clinical Oncology 1
Consider measuring thyroid antibodies (TPO) to evaluate for autoimmune thyroid disease as the underlying cause, according to the European Society for Medical Oncology 2
Rule out central hypothyroidism (pituitary or hypothalamic origin) which would present with low TSH and low free T4, as stated by the American College of Clinical Oncology 3

For patients without risk factors (under 70 years old, not frail, without cardiac disease), start with full replacement dose calculated at approximately 1.6 mcg/kg/day based on ideal body weight, as recommended by the American College of Clinical Oncology 1, 3
For elderly patients (>70 years), those with cardiac disease, or multiple comorbidities, start with a lower dose of 25-50 mcg daily and gradually titrate upward, according to the American College of Clinical Oncology and the Society for Immunotherapy of Cancer 1, 4
Beta-blockers may be used for symptomatic relief if thyrotoxic symptoms are present during initial treatment, as suggested by the European Society for Medical Oncology 2

Monitor TSH and free T4 every 6-8 weeks while titrating hormone replacement to achieve TSH within the reference range, as recommended by the American College of Clinical Oncology 1
Free T4 can help interpret ongoing abnormal TSH levels during therapy, as TSH may take longer to normalize, according to the American College of Clinical Oncology 1, 3
Once adequately treated, repeat testing every 6-12 months or if symptoms change, as stated by the American College of Clinical Oncology 1

If there is uncertainty about whether primary or central hypothyroidism is present, hydrocortisone should be given before thyroid hormone is initiated, as recommended by the American College of Clinical Oncology 1
For severe hypothyroidism with myxedema (bradycardia, hypothermia, altered mental status), hospitalization and endocrinology consultation are required, according to the American College of Clinical Oncology and the Society for Immunotherapy of Cancer 1, 4

For severe hypothyroidism with myxedema coma, immediate hospitalization, IV levothyroxine, and intensive care are required, as recommended by the American College of Clinical Oncology and the Society for Immunotherapy of Cancer 1, 4
Endocrinology consultation should be obtained for patients with severe symptoms or complicated presentations, as stated by the American College of Clinical Oncology 1

If TSH remains above reference range, increase thyroid hormone dose by 12.5-25 mcg, as recommended by the American Thyroid Association, with a moderate strength of evidence 5